KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Other Non Operating Income: 2011-2022

Historic Other Non Operating Income for TherapeuticsMD (TXMD) over the last 12 years, with Dec 2022 value amounting to -$117,000.

  • TherapeuticsMD's Other Non Operating Income rose 420.54% to $359,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $880,000, marking a year-over-year increase of 110.35%. This contributed to the annual value of -$117,000 for FY2022, which is 143.01% down from last year.
  • TherapeuticsMD's Other Non Operating Income amounted to -$117,000 in FY2022, which was down 143.01% from $272,000 recorded in FY2021.
  • Over the past 5 years, TherapeuticsMD's Other Non Operating Income peaked at $2.3 million during FY2018, and registered a low of -$10.1 million during FY2019.
  • In the last 3 years, TherapeuticsMD's Other Non Operating Income had a median value of $272,000 in 2021 and averaged $251,000.
  • In the last 5 years, TherapeuticsMD's Other Non Operating Income skyrocketed by 227.88% in 2018 and then plummeted by 540.98% in 2019.
  • Over the past 5 years, TherapeuticsMD's Other Non Operating Income (Yearly) stood at $2.3 million in 2018, then slumped by 540.98% to -$10.1 million in 2019, then surged by 105.95% to $598,000 in 2020, then slumped by 54.52% to $272,000 in 2021, then crashed by 143.01% to -$117,000 in 2022.